Laeverin/aminopeptidase Q, a novel bestatin-sensitive leucine aminopeptidase belonging to the M1 family of aminopeptidases. 2007

Masato Maruyama, and Akira Hattori, and Yoshikuni Goto, and Masamichi Ueda, and Michiyuki Maeda, and Hiroshi Fujiwara, and Masafumi Tsujimoto
Laboratory of Cellular Biochemistry, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.

Laeverin/aminopeptidase Q (APQ) is a cell surface protein specifically expressed on human embryo-derived extravillous trophoblasts that invades the uterus during placentation. The cDNA cloning of Laeverin/APQ revealed that the sequence encodes a protein with 990 amino acid residues, and Laeverin/APQ contains the HEXXHX(18)E gluzincin motif, which is characteristic of the M1 family of aminopeptidases, although the exopeptidase motif of the family, GAMEN, is uniquely substituted for the HAMEN sequence. In this study, we expressed a recombinant human Laeverin/APQ using a baculovirus expression system, purified to homogeneity, and characterized its enzymatic properties. It was found that Laeverin/APQ had a broad substrate specificity toward synthetic substrate, although it showed a preference for Leu-4-methylcoumaryl-7-amide. Searching natural substrates, we found that Laeverin/APQ was able to cleave the N-terminal amino acid of several peptides such as angiotensin III, kisspeptin-10, and endokinin C, which are abundantly expressed in the placenta. In contrast to the case with other M1 aminopeptidases, bestatin inhibited the aminopeptidase activity of Laeverin/APQ much more effectively than other known aminopeptidase inhibitors. These results indicate that Laeverin/APQ is a novel bestatin-sensitive leucine aminopeptidase and suggest that the enzyme plays important roles in human placentation by regulating biological activity of key peptides at the embryo-maternal interface.

UI MeSH Term Description Entries
D007930 Leucine An essential branched-chain amino acid important for hemoglobin formation. L-Leucine,Leucine, L-Isomer,L-Isomer Leucine,Leucine, L Isomer
D010929 Placentation The development of the PLACENTA, a highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products between mother and FETUS. The process begins at FERTILIZATION, through the development of CYTOTROPHOBLASTS and SYNCYTIOTROPHOBLASTS, the formation of CHORIONIC VILLI, to the progressive increase in BLOOD VESSELS to support the growing fetus. Hemochorial Placental Development,Hemochorial Placentation,Placental Development,Placental Development, Hemochorial,Placentation, Hemochorial
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities
D014327 Trophoblasts Cells lining the outside of the BLASTOCYST. After binding to the ENDOMETRIUM, trophoblasts develop into two distinct layers, an inner layer of mononuclear cytotrophoblasts and an outer layer of continuous multinuclear cytoplasm, the syncytiotrophoblasts, which form the early fetal-maternal interface (PLACENTA). Cytotrophoblasts,Syncytiotrophoblasts,Trophoblast,Cytotrophoblast,Syncytiotrophoblast

Related Publications

Masato Maruyama, and Akira Hattori, and Yoshikuni Goto, and Masamichi Ueda, and Michiyuki Maeda, and Hiroshi Fujiwara, and Masafumi Tsujimoto
August 2012, Current protein & peptide science,
Masato Maruyama, and Akira Hattori, and Yoshikuni Goto, and Masamichi Ueda, and Michiyuki Maeda, and Hiroshi Fujiwara, and Masafumi Tsujimoto
August 2011, Proceedings of the National Academy of Sciences of the United States of America,
Masato Maruyama, and Akira Hattori, and Yoshikuni Goto, and Masamichi Ueda, and Michiyuki Maeda, and Hiroshi Fujiwara, and Masafumi Tsujimoto
August 2009, Analytical biochemistry,
Masato Maruyama, and Akira Hattori, and Yoshikuni Goto, and Masamichi Ueda, and Michiyuki Maeda, and Hiroshi Fujiwara, and Masafumi Tsujimoto
September 2023, iScience,
Masato Maruyama, and Akira Hattori, and Yoshikuni Goto, and Masamichi Ueda, and Michiyuki Maeda, and Hiroshi Fujiwara, and Masafumi Tsujimoto
November 1976, Archives of biochemistry and biophysics,
Masato Maruyama, and Akira Hattori, and Yoshikuni Goto, and Masamichi Ueda, and Michiyuki Maeda, and Hiroshi Fujiwara, and Masafumi Tsujimoto
January 2011, Biological & pharmaceutical bulletin,
Masato Maruyama, and Akira Hattori, and Yoshikuni Goto, and Masamichi Ueda, and Michiyuki Maeda, and Hiroshi Fujiwara, and Masafumi Tsujimoto
December 1997, Antiviral research,
Masato Maruyama, and Akira Hattori, and Yoshikuni Goto, and Masamichi Ueda, and Michiyuki Maeda, and Hiroshi Fujiwara, and Masafumi Tsujimoto
December 2014, American journal of obstetrics and gynecology,
Masato Maruyama, and Akira Hattori, and Yoshikuni Goto, and Masamichi Ueda, and Michiyuki Maeda, and Hiroshi Fujiwara, and Masafumi Tsujimoto
November 1998, Molecular and biochemical parasitology,
Masato Maruyama, and Akira Hattori, and Yoshikuni Goto, and Masamichi Ueda, and Michiyuki Maeda, and Hiroshi Fujiwara, and Masafumi Tsujimoto
December 2018, ChemMedChem,
Copied contents to your clipboard!